Copyright
©The Author(s) 2021.
World J Clin Cases. Sep 26, 2021; 9(27): 8071-8081
Published online Sep 26, 2021. doi: 10.12998/wjcc.v9.i27.8071
Published online Sep 26, 2021. doi: 10.12998/wjcc.v9.i27.8071
Ref. | Sex | Age | Size (cm) | Location | Imaging features | Manifestation | Preoperative diagnosis | Therapy | Follow-up |
Fujino et al[5], 1998 | M | 61 | 2.5 × 2.0 × 1.8 | Uncinate process | CT: A solid mass. MRI: An isointensity lesion. CA: A hypervascular tumor | NF | Pan-NEN | PD | 5 yr PO (TF) |
Parithivel et al[6], 2000 | M | 85 | 6 | Head | CT: A highly vascular solid-cystic mass, no dilation of either biliary or pancreatic ducts | NF | NM | TLR | NM |
Ohkawara et al[7], 2005 | F | 72 | 4 | Head | CT: A solid-cystic tumor rich in blood supply, no dilation of either biliary or pancreatic ducts | NF | Pan-NEN | RPH | NM |
Kim et al[8], 2008 | F | 57 | 6.5 × 6 × 6 | Head | US: A hypervascular tumor. CT: Marked enhancement in the arterial phase, still well-enhancing in the portal venous phase, non-enhancing tubular-shaped portions could be seen inside. EUS: Echogenic mass with several anechoic portions | NF | Pancreatic islet cell tumor | PPPD | NM |
He et al[9], 2011 | F | 40 | 4.5 × 4.2 | Uncinate process | CT: Well demarcated solid mass, dramatical enhancement in pancreatic and portal vein phase, several low density foci were observed. Distal pancreatic duct middle dilation | NF | NM | RPH | NM |
Higa and Kapur[10], 2012 | F | 65 | 2.0 | Uncinate process | CT: A pancreatic mass with enhancement and mixed attenuation | NF | NM | PD | NM |
Al-Jiffry et al[11], 2013 | F | 19 | 9.0 | Head | CT: Marked enhancement in the arterial phase and washed out in the venous phase | F | Pancreatic sarcoma | PD | 3 yr PO (TF) |
Borgohain et al[12], 2013 | F | 55 | 17 × 19 | Tail | CT: A multi-cystic tumor. US: Highly vascular | NF | NM | TLR | 10 mo PO (TF) |
Straka et al[13], 2014 | F | 53 | 8.5 | Head | CT: An extremely hypervascular tumor with abundant collateral vessels from the superior mesenteric artery | NF | NM | PPPD | 49 mo PO (TF) |
Zhang et al[14], 2014 | F | 50 | 6 | Head | CT: A solid well-vascularized tumor, with multiple liver metastases | F | NM | Operation halted | 4 yr PO (TF) |
Zhang et al[14], 2014 | M | 63 | 4 | Head | CT: Well-vascularized tumor | F | NM | Operation | 3 mo PO (TF) |
Meng et al[15], 2015 | F | 54 | 3 × 2.5 | Head | US: An ill-defined hypoechoic mass, the blood flow signal was plentiful. CT: a poor-defined isodense mass, heterogeneous striking enhancement during the arterial phase, homogeneous marked enhancement during the venous phase | NF | NM | Operation | NM |
Meng et al[15], 2015 | F | 41 | 4 × 4 | Head | US: A well-demarcated hypoechoic mass, some blood flow signal was seen. CT: a poor-defined mass with low and heterogeneous density, marked enhancement | NF | NM | Operation | NM |
Misumi et al[16], 2015 | F | 47 | 1.5 × 1.2 | Head | US: A low-echoic tumor, CT: A well demarcated tumor, strongly enhanced in the arterial phase and still faintly enhanced in the portal vein phase. Feeding artery from the inferior pancreaticoduodenal artery and the draining vein into the portal vein. no dilation of either biliary or pancreatic ducts | NF | Pan-NEN | PD | 1 yr PO (TF) |
Ginesu et al[17], 2016 | M | 55 | 1.3 | Uncinate process | CT: Arterial phase hypervascularity and slow wash-out | NF | Pan-NEN | PPPD | 2 yr PO (TF) |
Tulumuru et al[18], 2016 | F | 62 | 2.8 × 2.8 × 2.7 | Body | CT: Well-defined margin and avid homogeneous enhancement. No lymphadenopathy or metastasis | NF | Pan-NEN | DP | 1 yr PO (TF) |
Lin et al[1], 2016 | F | 42 | 5.2 × 6.3 | Body | CT: Marked enhancement in the arterial phase, distal pancreatic duct dilation | NF | Pan-NEN | CP | 1 yr PO (TF) |
Furcea et al[19], 2017 | F | 53 | 3.5 × 2.5 × 2.5 | Isthmus | US: Encapsulated hypoechoic, inhomogeneous tumor. CEUS: intense arterial enhancement, rich arterial vascularization | NF | Pan-NEN | CP | NM |
Nonaka et al[20], 2017 | F | 68 | 2.2 × 2.2 × 1.7 | Head | EUS: Low-echoic nodule. No dilation of either biliary or pancreatic ducts. CT: enhanced during the arterial phase, weakly enhanced during the portal phase | NF | NM | PPPD | 1 yr PO (TF) |
- Citation: Jiang CN, Cheng X, Shan J, Yang M, Xiao YQ. Primary pancreatic paraganglioma harboring lymph node metastasis: A case report. World J Clin Cases 2021; 9(27): 8071-8081
- URL: https://www.wjgnet.com/2307-8960/full/v9/i27/8071.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i27.8071